Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease.
Gameiro I, Michalska P, Tenti G, Cores Á, Buendia I, Rojo AI, Georgakopoulos ND, Hernández-Guijo JM, Teresa Ramos M, Wells G, López MG, Cuadrado A, Menéndez JC, León R.
Gameiro I, et al. Among authors: cores a.
Sci Rep. 2017 Mar 31;7:45701. doi: 10.1038/srep45701.
Sci Rep. 2017.
PMID: 28361919
Free PMC article.